Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
- PMID: 28794145
- PMCID: PMC9488728
- DOI: 10.1183/16000617.0033-2017
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
Abstract
Previous methodological flaws led to erroneous conclusions on the effects of oxygen on exertional dyspnoea in ILD
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside this article at err.ersjournals.com
Figures

Comment in
-
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence.Eur Respir Rev. 2017 Aug 9;26(145):170072. doi: 10.1183/16000617.0072-2017. Print 2017 Sep 30. Eur Respir Rev. 2017. PMID: 28794146 Free PMC article.
Comment on
-
Oxygen therapy for interstitial lung disease: a systematic review.Eur Respir Rev. 2017 Feb 21;26(143):160080. doi: 10.1183/16000617.0080-2016. Print 2017 Jan. Eur Respir Rev. 2017. PMID: 28223395 Free PMC article.
References
-
- Nishiyama O, Miyajima H, Fukai Y, et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med 2013; 107: 1241–1246. - PubMed
-
- Frank RC, Hicks S, Duck AM, et al. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J 2012; 40: 269–270. - PubMed
-
- Visca D, Montgomery A, de Lauretis A, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J 2011; 38: 987–990. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical